Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Xue-Xiang Ye"'
Autor:
Yongfu Zhao, Gongquan Li, Hongbo Fang, Xue-Xiang Ye, Xiuxian Ma, Bing Yan, Shuijun Zhang, Liu-Shun Feng
Publikováno v:
Biochemical and Biophysical Research Communications. 434:809-814
Small-molecule Bcl-2/Bcl-xL inhibitor Navitoclax represents a promising cancer therapeutic since preclinical and clinical studies with Navitoclax have demonstrated strong anticancer activity in several types of cancers. However, because Navitoclax ha
Autor:
Yang Wu, Shuijun Zhang, Yu Wang, Gongquan Li, Xiu-Xian Ma, Baoming Qin, Xue-Xiang Ye, Guangzhi Liu, Yong-fu Zhao, Liu-Shun Feng, Jian-feng Lü, Gong Zhang
Publikováno v:
Cellular signalling. 24(9)
Small-molecule cell-permeable Bcl-2/Bcl-xL antagonist ABT-737 has recently emerged as a novel cancer therapeutic agent because it potently induces apoptosis in certain cancer cells. However, since ABT-737 binds to Mcl-1 with low affinity, ABT-737-med
Autor:
Liu-Shun, Feng, Qi-Ping, Peng, Ke, Li, Xiu-Xian, Ma, Yong-Fu, Zhao, Xue-Xiang, Ye, Pei-Qin, Xu, Xiao-Ping, Chen
Publikováno v:
Hepatobiliarypancreatic diseases international : HBPD INT. 3(4)
Budd-Chiari syndrome (BCS) is an uncommon disorder caused by the obstruction of hepatic venous outflow and/or the inferior vena cava. Major therapeutic approaches include operation and radiological intervention. This study was conducted to investigat
Autor:
Pei-Qin, Xu, Xiu-Xian, Ma, Xue-Xiang, Ye, Liu-Shun, Feng, Xiao-Wei, Dang, Yong-Fu, Zhao, Shui-Jun, Zhang, Long-Shuan, Zhao, Zhe, Tang, Xiu-Bo, Lu
Publikováno v:
Hepatobiliarypancreatic diseases international : HBPD INT. 3(3)
Budd-Chiari syndrome (BCS) is a disease caused by blood flow obstruction of the main hepatic veins (MHVs) and/or the outlet of the inferior vena cava (IVC), characterized by retrohepatic portal hypertension (PHT) and/or IVC hypertension. In the past
Publikováno v:
Hepatobiliarypancreatic diseases international : HBPD INT. 1(1)
To study the methods for diagnosis and treatment of insulinoma.Clinical data from 105 patients with insulinoma who had been admitted to our hospital from July 1966 to December 1999 were retrospectively reviewed.Fasting blood glucose values were less